Exhibit 10.1
JAZZ PHARMACEUTICALS PLC
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Non-employee members of the board of directors (the “Board”) of Jazz
Pharmaceuticals plc (the “Company”) shall be eligible to receive cash and equity
compensation as set forth in this Non-Employee Director Compensation Policy
(this “Policy”). The cash compensation and equity grants described in this
Policy shall be paid or be made, as applicable, automatically and without
further action of the Board, to each member of the Board who is not an employee
of the Company or any parent or subsidiary of the Company (each, a “Non-Employee
Director”) who may be eligible to receive such cash compensation or equity
grants, unless such Non-Employee Director declines the receipt of such cash
compensation or equity grants by written notice to the Company. This Policy
shall remain in effect until it is revised or rescinded by further action of the
Board.
1.    Cash Compensation.
(a)    Subject to Section 1(b) and Section 3 below, each Non-Employee Director
shall be eligible to receive an annual retainer of $60,000 for service on the
Board. In addition, a Non-Employee Director serving as:
(i)    lead independent director of the Board shall be eligible to receive an
additional annual retainer of $50,000 for such service;
(ii)    chairperson of the Audit Committee shall be eligible to receive an
additional annual retainer of $25,000 for such service;
(iii)    members (other than the chairperson) of the Audit Committee shall be
eligible to receive an additional annual retainer of $15,000 for such service;
(iv)    chairperson of the Compensation Committee shall be eligible to receive
an additional annual retainer of $22,500 for such service;
(v)    members (other than the chairperson) of the Compensation Committee shall
be eligible to receive an additional annual retainer of $12,500 for such
service;
(vi)    chairperson of the Nominating and Corporate Governance Committee shall
be eligible to receive an additional annual retainer of $20,000 for such
service;
(vii)    members (other than the chairperson) of the Nominating and Corporate
Governance Committee shall be eligible to receive an additional annual retainer
of $10,000 for such service;
(viii)    chairperson of the Transaction Committee shall be eligible to receive
an additional annual retainer of $22,500 for such service; and
(ix)    members (other than the chairperson) of the Transaction Committee shall
be eligible to receive an additional annual retainer of $12,500 for such
service.
The annual retainers shall be paid in four equal quarterly installments, earned
upon the completion of service in each calendar quarter.
(b)    Each person who is elected or appointed to be a Non-Employee Director or
who is appointed to serve as lead independent director or a member or
chairperson of one of the Committees described above, in each case other than on
the first day of a calendar quarter, shall be eligible to receive a pro rata
amount of the annual retainers described above with respect to the calendar
quarter in which such person becomes a Non-Employee Director, lead independent
director or a member or chairperson of one

--------------------------------------------------------------------------------

of the Committees, as applicable, which pro rata amount reflects a reduction for
each day during the calendar quarter prior to the date of such election or
appointment.
(c)    Each Non-Employee Director will be entitled to reimbursement from the
Company for his or her reasonable travel (including airfare and ground
transportation), lodging and meal expenses incidental to meetings of the Board
or committees thereof. If any reimbursement payment is subject to tax imposed by
the Irish Revenue Commissioners (“Revenue”), each Non-Employee Director will be
entitled to a payment, up to an amount (“Gross-Up Payment”) such that after the
deduction of all taxes (including, without limitation, any income taxes
calculated at the rate applicable to each Non-Employee Director for the year in
which the expenses were incurred) on the Gross-Up Payment, the Non-Employee
Director will retain an amount equal to the full reimbursement payment. All
taxes due will be paid by the Company to Revenue.
2.    Equity Compensation. The stock options and restricted stock unit (“RSU”)
awards described below shall be granted under and shall be subject to the terms
and provisions of the Company’s Amended and Restated 2007 Non-Employee Directors
Stock Award Plan (the “NEDSAP”).
(a)    Initial Grants. A person who is elected or appointed to be a Non-Employee
Director for the first time on or following 3 May 2018 automatically shall be
granted a nonstatutory stock option to purchase ordinary shares of the Company
(an “Initial Option Grant”) and an RSU award (an “Initial RSU Grant”), together
equal to a grant date value of approximately $600,000, on the second trading day
following the filing date of the Company’s next quarterly or annual report filed
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that
occurs after the date of such initial election or appointment. The Initial
Option Grant and Initial RSU Grant shall collectively be referred to as an
“Initial Grant.” The Initial Grant will be delivered such that approximately 50%
of the value is delivered as an Initial Option Grant and approximately 50% of
the value is delivered as an Initial RSU Grant, using the methodology for
determining actual share amounts and the stock option to RSU ratio most recently
approved by the Compensation Committee.
(b)    Continuing Grants. Subject to Section 2(c) below, a person who is a
Non-Employee Director on or following 3 May 2018 automatically shall be granted
a nonstatutory stock option to purchase ordinary shares of the Company (a
“Continuing Option Grant”) and an RSU award (a “Continuing RSU Grant”), together
equal to a grant date value of approximately $400,000, on the second trading day
following the filing date of the Company’s next quarterly or annual report filed
under the Exchange Act that occurs after the date of each annual general meeting
of the Company’s shareholders. The Continuing Option Grant and Continuing RSU
Grant shall collectively be referred to as a “Continuing Grant.” The Continuing
Grant will be delivered such that approximately 50% of the value is delivered as
a Continuing Option Grant and approximately 50% of the value is delivered as a
Continuing RSU grant, using the methodology for determining actual share amounts
and the stock option to RSU ratio most recently approved by the Compensation
Committee. Notwithstanding the foregoing, each person who is elected or
appointed to be a Non-Employee Director for the first time at an annual general
meeting of the Company’s shareholders shall not be granted a Continuing Grant
with respect to such meeting.
(c)    Continuing Grants for Certain New Non-Employee Directors. If a person is
elected or appointed to be a Non-Employee Director for the first time other than
at an annual general meeting of the Company’s shareholders, such Non-Employee
Director automatically shall be granted a Continuing Grant with respect to the
next annual general meeting in accordance with Section 2(b) above, provided that
the date of such initial election or appointment is not less than four calendar
months prior to the date of the next annual general meeting. If the date of such
initial election or appointment is less than four calendar months prior to the
date of the next annual general meeting, such Non-Employee Director shall not be
granted a Continuing Grant under Section 2(b) above with respect to such next
annual general meeting.

--------------------------------------------------------------------------------

(d)    Terms of Options Granted to Non-Employee Directors.
(i)    Terms and Conditions. The terms and conditions applicable to each Initial
Option Grant and Continuing Option Grant granted to Non-Employee Directors
pursuant to this Policy shall be subject to the terms and conditions in the
forms of stock option notice of grant and option award agreement previously
approved by the Board or the Compensation Committee and the NEDSAP.
(ii)    Vesting.
(a)    Each Initial Option Grant granted to a Non-Employee Director shall vest
and become exercisable as to 1/3 of the shares subject to such option on the
first anniversary of the date such Non-Employee Director is first elected or
appointed to the Board (the “Initial Grant Vesting Commencement Date”) and as to
the remainder of the shares, in 24 equal monthly installments thereafter,
subject to the Non-Employee Director’s Continuous Service (as defined in the
NEDSAP) through such dates.
(b)    Each Continuing Option Grant granted to a Non-Employee Director shall
vest and become exercisable in full on the first anniversary of the annual
general meeting of the Company’s shareholders in the year of grant, subject to
the Non-Employee Director’s Continuous Service (as defined in the NEDSAP)
through such date.
(c)    Notwithstanding the vesting provisions in clauses (a) and (b) hereof, if
a Non-Employee Director does not stand for reelection at an annual general
meeting of the Company’s shareholders in the year in which his or her term
expires or otherwise resigns effective at an annual general meeting of the
Company’s shareholders and, in either case, the Non-Employee Director’s
Continuous Service terminates at such annual general meeting, then effective as
of the date of such annual general meeting:
(1)    the unvested portion, if any, of an Initial Option Grant granted to such
Non-Employee Director shall become vested and exercisable with respect to the
portion of the Initial Option Grant that would have vested through the
anniversary of the Initial Grant Vesting Commencement Date in the year of such
annual general meeting; and
(2)    the unvested portion, if any, of a Continuing Option Grant granted to
such Non-Employee Director shall become vested and exercisable in full.
(e)    Terms of RSUs Granted to Non-Employee Directors.
(i)    Terms and Conditions. The terms and conditions applicable to each Initial
RSU Grant and Continuing RSU Grant granted to Non-Employee Directors pursuant to
this Policy shall be subject to the terms and conditions in the forms of RSU
notice of grant and RSU award agreement previously approved by the Board or the
Compensation Committee, as applicable, and the NEDSAP.
(ii)    Vesting.
(a)    Each Initial RSU Grant granted to a Non-Employee Director shall vest in
three equal annual installments on each of the first three anniversaries of the
Initial Grant Vesting Commencement Date, subject to the Non-Employee Director’s
Continuous Service (as defined in the NEDSAP) through such dates.
(b)    Each Continuing RSU Grant granted to a Non-Employee Director shall vest
in full on the first anniversary of the annual general meeting of the Company’s
shareholders in the year of grant, subject to the Non-Employee Director’s
Continuous Service (as defined in the NEDSAP) through such date.

--------------------------------------------------------------------------------

(c)    Notwithstanding the vesting provisions in clauses (a) and (b) hereof, if
a Non-Employee Director does not stand for reelection at an annual general
meeting of the Company’s shareholders in the year in which his or her term
expires or otherwise resigns effective at an annual general meeting of the
Company’s shareholders and, in either case, the Non-Employee Director’s
Continuous Service terminates at such annual general meeting, then effective as
of the date of such annual general meeting:
(1)    the unvested portion, if any, of an Initial RSU Grant granted to such
Non-Employee Director shall become vested with respect to the portion of the
Initial RSU Grant that would have vested on the anniversary of the Initial Grant
Vesting Commencement Date in the year of such annual general meeting; and
(2)    the unvested portion, if any, of a Continuing RSU Grant granted to such
Non-Employee Director shall become vested in full.
3.    Non-Employee Director Compensation Limit. The aggregate value of all
compensation granted or paid, as applicable, by the Company to any individual
for service as a Non-Employee Director with respect to any period commencing on
the date of the annual general meeting of the Company’s shareholders for a
particular year and ending on the day immediately prior to the date of the
annual general meeting of the Company’s shareholders for the subsequent year
(the “Annual Period”), including equity awards granted and cash fees paid by the
Company to such Non-Employee Director, will not exceed (i) $750,000 in total
value or (ii) in the event such Non-Employee Director is first appointed or
elected to the Board during such Annual Period, $1,350,000 in total value, in
each case calculating the value of any equity awards based on the grant date
fair value of such equity awards for financial reporting purposes.
*****
Adopted by the Board of Directors of Jazz Pharmaceuticals plc on 2 May 2013.
Amended and restated by the Board of Directors of Jazz Pharmaceuticals plc on 1
August 2013.
Amended and restated by the Board of Directors of Jazz Pharmaceuticals plc on 1
May 2014.
Amended and restated by the Board of Directors of Jazz Pharmaceuticals plc on 30
October 2014.
Amended and restated by the Board of Directors of Jazz Pharmaceuticals plc on 30
April 2015.
Amended and restated by the Board of Directors of Jazz Pharmaceuticals plc on 4
May 2016.
Amended and restated by the Board of Directors of Jazz Pharmaceuticals plc on 3
May 2018.
Amended and restated by the Board of Directors of Jazz Pharmaceuticals plc on 21
July 2020.